Tamoxifen protects male mice nigrostriatal dopamine against methamphetamine-induced toxicity
Identifieur interne : 002638 ( Main/Exploration ); précédent : 002637; suivant : 002639Tamoxifen protects male mice nigrostriatal dopamine against methamphetamine-induced toxicity
Auteurs : Mélanie Bourque [Canada] ; BIN LIU [États-Unis] ; Dean E. Dluzen [États-Unis] ; Therese Di Paolo [Canada]Source :
- Biochemical pharmacology [ 0006-2952 ] ; 2007.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
Abstract
The selective estrogen receptor modulator tamoxifen and estradiol were shown to protect nigrostriatal dopamine concentration loss by methamphetamine in female mice whereas male mice were protected only by tamoxifen. The present study examined the protective properties of tamoxifen in male mice on several nigrostriatal dopaminergic markers and body temperature. Intact male mice were administered 12.5 or 50 μg tamoxifen 24 h before methamphetamine treatment. Basal body temperatures of male mice remained unchanged by the tamoxifen treatment. Methamphetamine reduced striatal dopamine and its metabolites 3,4-dihydroxyphenylacetic acid and homovanillic acid concentrations, striatal and substantia nigra dopamine and vesicular monoamine transporter specific binding as well substantia nigra dopamine and vesicular monoamine transporter mRNA levels and increased striatal preproenkephalin mRNA levels. These methamphetamine effects were not altered by 12.5 μg tamoxifen except for increased striatal dopamine metabolites and turnover. Tamoxifen at 50 μg reduced the methamphetamine effect on striatal dopamine concentration, dopamine transporter specific binding and prevented the increase in preproenkephalin mRNA levels; in the substantia nigra tamoxifen prevented the decrease of dopamine transporter mRNA levels. The present results show a tamoxifen dose-dependent prevention of loss of various dopaminergic markers against methamphetamine-induced toxicity in male mice. Since this is the only known hormonal protection of male mice against methamphetamine toxicity, these findings provide important new information on specific parameters of nigrostriatal dopaminergic function preserved by tamoxifen.
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: 000701
- to stream PascalFrancis, to step Curation: 000619
- to stream PascalFrancis, to step Checkpoint: 000594
- to stream Main, to step Merge: 002884
- to stream Main, to step Curation: 002638
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Tamoxifen protects male mice nigrostriatal dopamine against methamphetamine-induced toxicity</title><author><name sortKey="Bourque, Melanie" sort="Bourque, Melanie" uniqKey="Bourque M" first="Mélanie" last="Bourque">Mélanie Bourque</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Molecular Endocrinology and Oncology Research Center, Laval University Medical Center, CHUL</s1><s2>Quebec City, Quebec G1V 4G2</s2><s3>CAN</s3><sZ>1 aut.</sZ><sZ>4 aut.</sZ></inist:fA14><country>Canada</country><wicri:noRegion>Quebec City, Quebec G1V 4G2</wicri:noRegion></affiliation><affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Faculty of Pharmacy, Laual University</s1><s2>Quebec City, Quebec G1K 7P4</s2><s3>CAN</s3><sZ>1 aut.</sZ><sZ>4 aut.</sZ></inist:fA14><country>Canada</country><wicri:noRegion>Quebec City, Quebec G1K 7P4</wicri:noRegion></affiliation></author><author><name sortKey="Bin Liu" sort="Bin Liu" uniqKey="Bin Liu" last="Bin Liu">BIN LIU</name><affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Anatomy, Northeastern Ohio Universities College of Medicine (NEOUCOM)</s1><s2>Roots town, OH 44272</s2><s3>USA</s3><sZ>2 aut.</sZ><sZ>3 aut.</sZ></inist:fA14><country>États-Unis</country><wicri:noRegion>Roots town, OH 44272</wicri:noRegion></affiliation></author><author><name sortKey="Dluzen, Dean E" sort="Dluzen, Dean E" uniqKey="Dluzen D" first="Dean E." last="Dluzen">Dean E. Dluzen</name><affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Anatomy, Northeastern Ohio Universities College of Medicine (NEOUCOM)</s1><s2>Roots town, OH 44272</s2><s3>USA</s3><sZ>2 aut.</sZ><sZ>3 aut.</sZ></inist:fA14><country>États-Unis</country><wicri:noRegion>Roots town, OH 44272</wicri:noRegion></affiliation></author><author><name sortKey="Di Paolo, Therese" sort="Di Paolo, Therese" uniqKey="Di Paolo T" first="Therese" last="Di Paolo">Therese Di Paolo</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Molecular Endocrinology and Oncology Research Center, Laval University Medical Center, CHUL</s1><s2>Quebec City, Quebec G1V 4G2</s2><s3>CAN</s3><sZ>1 aut.</sZ><sZ>4 aut.</sZ></inist:fA14><country>Canada</country><wicri:noRegion>Quebec City, Quebec G1V 4G2</wicri:noRegion></affiliation><affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Faculty of Pharmacy, Laual University</s1><s2>Quebec City, Quebec G1K 7P4</s2><s3>CAN</s3><sZ>1 aut.</sZ><sZ>4 aut.</sZ></inist:fA14><country>Canada</country><wicri:noRegion>Quebec City, Quebec G1K 7P4</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">INIST</idno><idno type="inist">07-0502377</idno><date when="2007">2007</date><idno type="stanalyst">PASCAL 07-0502377 INIST</idno><idno type="RBID">Pascal:07-0502377</idno><idno type="wicri:Area/PascalFrancis/Corpus">000701</idno><idno type="wicri:Area/PascalFrancis/Curation">000619</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">000594</idno><idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000594</idno><idno type="wicri:doubleKey">0006-2952:2007:Bourque M:tamoxifen:protects:male</idno><idno type="wicri:Area/Main/Merge">002884</idno><idno type="wicri:Area/Main/Curation">002638</idno><idno type="wicri:Area/Main/Exploration">002638</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Tamoxifen protects male mice nigrostriatal dopamine against methamphetamine-induced toxicity</title><author><name sortKey="Bourque, Melanie" sort="Bourque, Melanie" uniqKey="Bourque M" first="Mélanie" last="Bourque">Mélanie Bourque</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Molecular Endocrinology and Oncology Research Center, Laval University Medical Center, CHUL</s1><s2>Quebec City, Quebec G1V 4G2</s2><s3>CAN</s3><sZ>1 aut.</sZ><sZ>4 aut.</sZ></inist:fA14><country>Canada</country><wicri:noRegion>Quebec City, Quebec G1V 4G2</wicri:noRegion></affiliation><affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Faculty of Pharmacy, Laual University</s1><s2>Quebec City, Quebec G1K 7P4</s2><s3>CAN</s3><sZ>1 aut.</sZ><sZ>4 aut.</sZ></inist:fA14><country>Canada</country><wicri:noRegion>Quebec City, Quebec G1K 7P4</wicri:noRegion></affiliation></author><author><name sortKey="Bin Liu" sort="Bin Liu" uniqKey="Bin Liu" last="Bin Liu">BIN LIU</name><affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Anatomy, Northeastern Ohio Universities College of Medicine (NEOUCOM)</s1><s2>Roots town, OH 44272</s2><s3>USA</s3><sZ>2 aut.</sZ><sZ>3 aut.</sZ></inist:fA14><country>États-Unis</country><wicri:noRegion>Roots town, OH 44272</wicri:noRegion></affiliation></author><author><name sortKey="Dluzen, Dean E" sort="Dluzen, Dean E" uniqKey="Dluzen D" first="Dean E." last="Dluzen">Dean E. Dluzen</name><affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Anatomy, Northeastern Ohio Universities College of Medicine (NEOUCOM)</s1><s2>Roots town, OH 44272</s2><s3>USA</s3><sZ>2 aut.</sZ><sZ>3 aut.</sZ></inist:fA14><country>États-Unis</country><wicri:noRegion>Roots town, OH 44272</wicri:noRegion></affiliation></author><author><name sortKey="Di Paolo, Therese" sort="Di Paolo, Therese" uniqKey="Di Paolo T" first="Therese" last="Di Paolo">Therese Di Paolo</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Molecular Endocrinology and Oncology Research Center, Laval University Medical Center, CHUL</s1><s2>Quebec City, Quebec G1V 4G2</s2><s3>CAN</s3><sZ>1 aut.</sZ><sZ>4 aut.</sZ></inist:fA14><country>Canada</country><wicri:noRegion>Quebec City, Quebec G1V 4G2</wicri:noRegion></affiliation><affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Faculty of Pharmacy, Laual University</s1><s2>Quebec City, Quebec G1K 7P4</s2><s3>CAN</s3><sZ>1 aut.</sZ><sZ>4 aut.</sZ></inist:fA14><country>Canada</country><wicri:noRegion>Quebec City, Quebec G1K 7P4</wicri:noRegion></affiliation></author></analytic><series><title level="j" type="main">Biochemical pharmacology</title><title level="j" type="abbreviated">Biochem. pharmacol.</title><idno type="ISSN">0006-2952</idno><imprint><date when="2007">2007</date></imprint></series></biblStruct></sourceDesc><seriesStmt><title level="j" type="main">Biochemical pharmacology</title><title level="j" type="abbreviated">Biochem. pharmacol.</title><idno type="ISSN">0006-2952</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animal</term><term>Antineoplastic agent</term><term>Corpus striatum</term><term>Dopamine</term><term>Locus niger</term><term>Male</term><term>Metamfetamine</term><term>Mouse</term><term>Neuroprotection</term><term>Nigrostriatal pathway</term><term>Parkinson disease</term><term>Prevention</term><term>Psychotropic</term><term>Tamoxifene</term><term>Toxicity</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Tamoxifène</term><term>Prévention</term><term>Mâle</term><term>Animal</term><term>Souris</term><term>Voie nigrostriatale</term><term>Dopamine</term><term>Métamfétamine</term><term>Toxicité</term><term>Corps strié</term><term>Locus niger</term><term>Neuroprotection</term><term>Parkinson maladie</term><term>Anticancéreux</term><term>Psychotrope</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The selective estrogen receptor modulator tamoxifen and estradiol were shown to protect nigrostriatal dopamine concentration loss by methamphetamine in female mice whereas male mice were protected only by tamoxifen. The present study examined the protective properties of tamoxifen in male mice on several nigrostriatal dopaminergic markers and body temperature. Intact male mice were administered 12.5 or 50 μg tamoxifen 24 h before methamphetamine treatment. Basal body temperatures of male mice remained unchanged by the tamoxifen treatment. Methamphetamine reduced striatal dopamine and its metabolites 3,4-dihydroxyphenylacetic acid and homovanillic acid concentrations, striatal and substantia nigra dopamine and vesicular monoamine transporter specific binding as well substantia nigra dopamine and vesicular monoamine transporter mRNA levels and increased striatal preproenkephalin mRNA levels. These methamphetamine effects were not altered by 12.5 μg tamoxifen except for increased striatal dopamine metabolites and turnover. Tamoxifen at 50 μg reduced the methamphetamine effect on striatal dopamine concentration, dopamine transporter specific binding and prevented the increase in preproenkephalin mRNA levels; in the substantia nigra tamoxifen prevented the decrease of dopamine transporter mRNA levels. The present results show a tamoxifen dose-dependent prevention of loss of various dopaminergic markers against methamphetamine-induced toxicity in male mice. Since this is the only known hormonal protection of male mice against methamphetamine toxicity, these findings provide important new information on specific parameters of nigrostriatal dopaminergic function preserved by tamoxifen.</div></front></TEI><affiliations><list><country><li>Canada</li><li>États-Unis</li></country></list><tree><country name="Canada"><noRegion><name sortKey="Bourque, Melanie" sort="Bourque, Melanie" uniqKey="Bourque M" first="Mélanie" last="Bourque">Mélanie Bourque</name></noRegion><name sortKey="Bourque, Melanie" sort="Bourque, Melanie" uniqKey="Bourque M" first="Mélanie" last="Bourque">Mélanie Bourque</name><name sortKey="Di Paolo, Therese" sort="Di Paolo, Therese" uniqKey="Di Paolo T" first="Therese" last="Di Paolo">Therese Di Paolo</name><name sortKey="Di Paolo, Therese" sort="Di Paolo, Therese" uniqKey="Di Paolo T" first="Therese" last="Di Paolo">Therese Di Paolo</name></country><country name="États-Unis"><noRegion><name sortKey="Bin Liu" sort="Bin Liu" uniqKey="Bin Liu" last="Bin Liu">BIN LIU</name></noRegion><name sortKey="Dluzen, Dean E" sort="Dluzen, Dean E" uniqKey="Dluzen D" first="Dean E." last="Dluzen">Dean E. Dluzen</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002638 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002638 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= Pascal:07-0502377
|texte= Tamoxifen protects male mice nigrostriatal dopamine against methamphetamine-induced toxicity
}}
| This area was generated with Dilib version V0.6.29. |  |